A retrospective, matched paired analysis comparing bendamustine containing BeEAM versus BEAM conditioning regimen: results from a single center experience

K Saleh, A Danu, S Koscielny, C Legoupil… - Leukemia & …, 2018 - Taylor & Francis
The combination of carmustine, etoposide, aracytin, and melphalan (BEAM) conditioning
regimen in autologous stem-cell transplantation (ASCT) is widely used in patients with …
被引用次数：26 相关文章

A retrospective, matched paired analysis comparing bendamustine containing BeEAM versus BEAM conditioning regimen: results from a single center experience.

K Saleh, A Danu, S Koscielny… - Leukemia & …, 2018 - search.ebscohost.com
The combination of carmustine, etoposide, aracytin, and melphalan (BEAM) conditioning
regimen in autologous stem-cell transplantation (ASCT) is widely used in patients with …

A retrospective, matched paired analysis comparing bendamustine containing BeEAM versus BEAM conditioning regimen: results from a single center experience

K Saleh, A Danu, S Koscielny… - Leukemia & …, 2018 - pubmed.ncbi.nlm.nih.gov
The combination of carmustine, etoposide, aracytin, and melphalan (BEAM) conditioning
regimen in autologous stem-cell transplantation (ASCT) is widely used in patients with …

A retrospective, matched paired analysis comparing bendamustine containing BeEAM versus BEAM conditioning regimen: results from a single center experience.

K Saleh, A Danu, S Koscielny, C Legoupil… - Leukemia & …, 2017 - europepmc.org
The combination of carmustine, etoposide, aracytin, and melphalan (BEAM) conditioning
regimen in autologous stem-cell transplantation (ASCT) is widely used in patients with …